Skip to main content

Search

Clear
Filter by Type
Filter by Topics
Filter by Symptoms & Conditions
Filter by Year
Inappropriate Use of Artificial Intelligence by Payers

Sep 23, 2024/Policies & Bylaws

House position: Describes the association's position on the inappropriate use of artificial intelligence by payers.

Payment and Regulatory Update: Nov. 30, 2022

Nov 30, 2022/Members Only

Topics discussed: 2023 Medicare Fee Schedule, 2023 Home Health Rule, Commercial Payer Update.

Epworth Sleepiness Scale (ESS)

Jul 21, 2022/Test & Measure

This summary measures an individual's chances of having dozed off or fallen asleep during different activities in daily life and contains information on the use of this assessment in patients who experience daytime sleepiness.

Payment and Regulatory Update: May 18, 2022

May 18, 2022/Members Only

Topics discussed: PHE Update, Regulatory Update, Commercial Payer Update.

Access to, Admission to, and Patient/Client Rights Within Physical Therapy Services

Aug 30, 2018/Policies & Bylaws

House position: In providing physical therapy services, the physical therapist is accountable first and foremost to the individual receiving physical therapy.

APTA Life Member Application

Jan 1, 2025/Form

Continue to enjoy APTA's many member benefits, stay connected, and support your profession—all at reduced dues rates.

Guidelines: Commitment of Students and Clinicians to Patients, Clients, Society, and the Profession

Aug 20, 2020/Policies & Bylaws

House guideline: APTA supports students, PTs, and PTAs expressing their commitment to patients, clients, society, and the profession with an oath or pledge.

Pro Bono Physical Therapist Services

Pro bono services are consistent with our profession’s values and vision.

Pain Management

The CDC recommends safe alternatives like physical therapy to manage most pain.

Coronavirus Update: March 23, 2020

Mar 23, 2020/News

Tips on what to ask about telehealth; guidance on paid leave law; coronavirus "self-checker"; CMS enrollment relief, and more.